Skip to main content
SpringerLink
Log in

What is the place of conservative management for adult supratentorial low-grade glioma?

  • Chapter
Low-Grade Gliomas

Part of the book series: Advances and Technical Standards in Neurosurgery ((NEUROSURGERY,volume 35))

Abstract

Adult supratentorial low-grade gliomas (LGG) cover a spectrum of neuropathologies that invariably present with seizure disorders. Following neuroradiological diagnosis management strategy will be determined by prognostic indicators such as patient age, lesion size, lesion location, clinical performance status and radiological differential diagnosis. Conservative management, characterised by a “watch and wait” policy, with serial neuroimaging and clinical observation, may form an integral part of overall Multi-Disciplinary Team management strategy in many patients. Conservative management may include the periods following radiological diagnosis to primary surgery, and from the time of surgery to timing of radiotherapy or chemotherapy. Results from randomised controlled clinical trials in LGG, recent findings following microsurgical excision, findings from serial observations using volumetric MRI, and recent findings following chemotherapy and tumour genotyping have helped in defining the place of conservative management in individual cases. These recent findings have moved conservative management from a ‘controversial’ legacy of a bygone era to a more objectively based coherent management component that is understood by both medical and surgical neuro-oncologists. However there is still no evidence from randomised controlled trials to either support or indict the role of conservative management, prior to primary intervention, in LGG. Informing patients of the uncertainties in both interventional strategies and the place of conservative management in LGG is essential in optimising patient outcomes and satisfaction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG (1999) Pretreatment factors predict overall survival for patients with lowgrade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45(4): 923–29

    PubMed  CAS  Google Scholar 

  2. Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74(6): 1784–91

    Article  PubMed  CAS  Google Scholar 

  3. Cairncross JG, Laperriere NJ (1989) Low-grade glioma. To treat or not to treat? Arch Neurol 46(11): 1238–39

    PubMed  CAS  Google Scholar 

  4. Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A (2009) Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature. Neurol Res [Epub ahead of print]

    Google Scholar 

  5. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM (2008) Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 109(5): 817–24

    Article  PubMed  Google Scholar 

  6. Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR (2008) Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247(1): 170–78

    Article  PubMed  Google Scholar 

  7. Duffau H (2006) Management of low-grade gliomas. Rev Prat [Article in French] 56(16): 1771–77

    Google Scholar 

  8. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Lopes M, Mitchell MC, Sichez JP, Van Effenterre R (2003) Functional recovery after surgical resection of low-grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry 74(7): 901–07

    Article  PubMed  CAS  Google Scholar 

  9. Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulations in surgery of low-grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76(6): 845–51

    Article  PubMed  CAS  Google Scholar 

  10. Feigenberg SJ, Amdur RJ, Morris CG, Mendenhall WM, Marcus RB Jr, Friedman WA (2003) Oligodendroglioma: does deferring treatment compromise outcome? Am J Clin Oncol 26(3): e60–66

    Article  PubMed  Google Scholar 

  11. Guidelines and Outcomes Committee of the American Association of Neurological Surgeons (AANS) (1998) Practice parameters in adults with suspected or known supratentorial nooptic pathway low-grade glioma. Neurosurg Focus 4(6): 10

    Article  Google Scholar 

  12. Guillevin R, Menuel C, Duffau H, Kujas M, Capelle L, Aubert A, Taillibert S, Idbaih A, Pallud J, Demarco G, Costalat R, Hoang-Xuan K, Chiras J, Vallèe JN (2008) Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas. J Neurooncol 87(2): 181–87

    Article  PubMed  CAS  Google Scholar 

  13. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Crinière E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broët P, Sanson M, Delattre JY (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22(15): 3133–38

    Article  PubMed  CAS  Google Scholar 

  14. Janny P, Cure H, Mohr M, Heldt N, Kwiatkowski F, Lemaire JJ, Plagne R, Rozan R (1994) Low grade supratentorial astrocytomas. Management and prognostic factors. Cancer 73(7): 1937–45

    Article  PubMed  CAS  Google Scholar 

  15. Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 129(Pt 7): 1884–91

    Article  PubMed  Google Scholar 

  16. Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study (22845) with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52(2): 316–24

    PubMed  Google Scholar 

  17. Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95(5): 735–45

    Article  PubMed  CAS  Google Scholar 

  18. Kortmann RD, Jeremic B, Weller M, Lutterbach J, Paulsen F, Bamberg M (2004) Immediate postoperative radiotherapy or “watch and wait” in the management of adult low-grade glioma? Strahlenther Onkol 180(7): 408–18

    Article  PubMed  Google Scholar 

  19. Kujas M, Lejeune J, Benouaich-Amiel A, Crinière E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka M, Bernier M, Chretien F, Couvelard A, Capelle L, Duffau H, Cornu P, Broët P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K, Delattre JY (2005) Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol 58(2): 322–26

    Article  PubMed  CAS  Google Scholar 

  20. Lang FF, Olansen NE, Demonte F, Gokaslan ZL, et al. (2001) Surgical resection of intrinsic insula tumours: complication avoidance. J Neurosurg 95: 638–50

    Article  PubMed  CAS  Google Scholar 

  21. Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G (2006) Lowgrade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging — prediction of patient clinical response. Radiology 238(2): 658–67

    Article  PubMed  Google Scholar 

  22. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC Jr, Capelle L (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53(4): 524–28

    Article  PubMed  Google Scholar 

  23. Mandonnet E, Pallud J, Clatz O, Taillandier L, Konukoglu E, Duffau H, Capelle L (2008) Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev 31(3): 263–69 [Epub 2008 Feb 26]

    Article  PubMed  Google Scholar 

  24. Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8): 1305–09

    Article  PubMed  Google Scholar 

  25. Meyer FB, Bates LM, Goerss SJ, Friedman JA, Windschitl WL, Duffy JR, Perkins WJ, O’Neill BP (2001) Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76(7): 677–87

    Article  PubMed  CAS  Google Scholar 

  26. Papagikos MA, Shaw EG, Stieber VW (2005) Lessons learned from randomised clinical trials in adult low-grade glioma. Lancet Oncol 6(4): 240–44

    Article  PubMed  Google Scholar 

  27. Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, Bauchet L, Peruzzi P, Laigle-Donadey F, Kujas M, Guyotat J, Baron MH, Mokhtari K, Duffau H (2008) Prognostic Significance of Imaging Contrast Enhancement for WHO grade II Gliomas. Neuro Oncol [Epub ahead of print]

    Google Scholar 

  28. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, Taillandier L, Capelle L (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60(3): 380–83

    Article  PubMed  Google Scholar 

  29. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, Afra D, Cornu P, Bolla M, Vecht C, Karim AB; European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group; European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20(8): 2076–84

    Article  PubMed  Google Scholar 

  30. Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM, McLendon RE, Gururangan S, Bigner DD, Herndon JE 2nd, Avgeropoulos N, Finlay J, Tourt-Uhlig S, Affronti ML, Evans B, Stafford-Fox V, Zaknoen S, Friedman HS (2003) Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 21(4): 646–51

    Article  PubMed  CAS  Google Scholar 

  31. Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31(4): 431–36

    Article  PubMed  CAS  Google Scholar 

  32. Rees J, Watt H, Jäager HR, Benton C, Tozer D, Tofts P (2008) Waldman volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol [Epub ahead of print]

    Google Scholar 

  33. Reijneveld JC, van der Grond J, Ramos LM, Bromberg JE, Taphoorn MJ (2005) Proton MRS imaging in the follow-up of patients with uspected low-grade gliomas. Neuroradiology 47(12): 887–91 [Epub 2005 Aug 20]

    Article  PubMed  CAS  Google Scholar 

  34. Reijneveld JC, Sitskoorn MM, Klein M, Nuyen J, Taphoorn MJ (2001) Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56(5): 618–23

    PubMed  CAS  Google Scholar 

  35. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E, Kujas M, Mokhtari K, Taillibert S, Laigle-Donadey F, Carpentier AF, Omuro A, Capelle L, Duffau H, Cornu P, Guillevin R, Sanson M, Hoang-Xuan K, Delattre JY (2007) Dynamic history of lowgrade gliomas before and after temozolomide treatment. Ann Neurol 61(5): 484–90

    Article  PubMed  CAS  Google Scholar 

  36. Schneider JP, Schulz T, Schmidt F, Dietrich J, Lieberenz S, Trantakis C, Seifert V, Kellermann S, Schober R, Schaffranietz L, Laufer M, Kahn T (2001) Gross-total surgery of supratentorial low-grade gliomas under intraoperative MR guidance. Am J Neuroradiol 22(1): 89–98

    PubMed  CAS  Google Scholar 

  37. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59(6): 947–49

    PubMed  CAS  Google Scholar 

  38. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26(8): 1338–45

    Article  PubMed  Google Scholar 

  39. Van den Bent MJ (2003) Low-grade gliomas: how should patients be managed? In: Williams C (ed) Evidence based oncology. BMJ Publishing, London, pp 561–64

    Chapter  Google Scholar 

  40. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64(5): 581–87

    Article  PubMed  Google Scholar 

  41. Vecht CJ (1993) Effect of age on treatment decisions in low-grade glioma. J Neurol Neurosurg Psychiatry 56(12): 1259–64

    Article  PubMed  CAS  Google Scholar 

  42. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A (2003) Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2(7): 395–403

    Article  PubMed  Google Scholar 

  43. Whittle IR 2004. The dilemma of low-grade glioma. J Neurol Neurosurg Psychiatry 75 (Suppl 2): ii31–36

    Google Scholar 

  44. Whittle IR, Borthwick S, Haq N (2003) Brain dysfunction following ‘awake’ craniotomy, brain mapping and resection of glioma. Br J Neurosurg 17ai](2): 130–37

    Article  PubMed  CAS  Google Scholar 

  45. Yaşargil MG, von Ammon K, Cavazos E, Doczi T, Reeves JD, Roth P (1992) Tumours of the limbic and paralimbic systems. Acta Neurochir (Wien) 118(1–2): 40–52

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK

    I. R. Whittle

Authors
  1. I. R. Whittle
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

J. Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Whittle, I.R. (2010). What is the place of conservative management for adult supratentorial low-grade glioma?. In: Schramm, J. (eds) Low-Grade Gliomas. Advances and Technical Standards in Neurosurgery, vol 35. Springer, Vienna. https://doi.org/10.1007/978-3-211-99481-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-99481-8_3

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-99480-1

  • Online ISBN: 978-3-211-99481-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation